(RESEARCH TRIANGLE PARK, NC) Paidion Research, Inc., a new clinical research organization (CRO) focused exclusively on pediatrics and specializing in NICU and PICU populations (neonatal and pediatric intensive care), recently opened for business. Headquartered on Leigh Farm Road in Durham, Paidion combines pediatric clinical pharmacology expertise with innovative pediatric regulatory strategies and trial methodologies to provide best-in-class service to drug and device development partners in industry, government, academia and nonprofits.
Recently, the FDA and EMA (European Medicines Agency) made significant changes in their regulations and now require a pediatric component for all drug research. Paidion is a global CRO that helps organizations develop and execute clinical trials that meet the new pediatric requirements quickly, efficiently and cost-effectively.
Led by veteran research executives with more than 30 years of experience in academia, CROs, and pharmaceutical companies, Paidion’s highly experienced project teams deliver cost-effective, efficient and timely clinical trial results for Phase I/II, Phase III and long-term follow-up pediatric studies. For more about the company, visit their recently launched website www.paidionresearch.com or email email@example.com.